Phase Ii study of isotretinoin in the treatment of advanced non-small cell lung cancer
Grunberg, S.M.; Itri, L.M.
Cancer Treatment Reports 71(11): 1097-1098
1987
ISSN/ISBN: 0361-5960 PMID: 2824046 Document Number: 291171
Document emailed within 1 workday
Related Documents
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Smith, D.B.; Thatcher, N.; Steward, W.P.; Brear, G.; Carroll, K.B. 1986: A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology 22(4): 435-437
Thongprasert, S.; Soorraritchingchai, S.; Chewaskulyong, B.; Charoentum, C.; Munprakan, S. 2006: A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer Journal of the Medical Association of Thailand 89(2): 152-159
Ciuleanu, T.E.; Curcă, R.; Iancu, D.; Todor, N.; Cebotaru, C.; Radulescu, I.; Banu, E.; Ghilezan, N. 2002: First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. a phase Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 7(1): 43-46
Mori, K.; Kamiyama, Y.; Kondoh, T.; Tominaga, K. 2002: Phase II study of combined Vinorelbine (Navelbine) plus cisplatin for advanced non-small cell lung cancer (an interim report) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(3): 405-410
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Charoentum, C.; Thongprasert, S.; Chewasakulyong, B.; Euathrongchit, J.; Sorraritchingchai, S.; Munprakan, S. 2007: Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 90(11): 2506-2512
Vogt, H.G.; Kolotas, C.; Martin, T.; Schneider, L.V.; Goes-Schmieder, R.; Mitrou, P.S.; Diergarten, K.; Kober, B.; Zamboglou, N. 1996: Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase i study Seminars in Oncology 23(6 Suppl 16: 120-123
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Roychowdhury, D.F.; Desai, P.; Zhu, Y.W. 1997: Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase Ii study in advanced non-small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Gridelli, C.; Frontini, L.; Barletta, E.; Rossi, A.; Barzelloni, M.L.; Scognamiglio, F.; Guida, C.; Gatani, T.; Fiore, F.; De Bellis, M.; Marfella, A.; Manzione, L. 2000: Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature Anticancer Research 20(2b): 1077-1084
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Yoshimura, A.; Yamano, Y.; Gemma, A.; Yoshimori, K.; Hayashihara, K.; Taniguchi, Y.; Uematsu, K.; Shibuya, M.; Kudoh, S.; Niitani, H. 1993: An early phase Ii trial combining cisplatin and carboplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 503-508
Adam, Z.; Coupková, H.; Kolek, V.; Kucera, M.; Loffelmann, L.; Martinez, A.; Nováková, M.; Průsa, P.; Reiterer, P.; Skalová, B. 1995: Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study Acta Medica Austriaca 22(5): 120-124
Ratanatharathorn, V.; Jirajarus, M.; Sirachainan, E.; Sirilerttrakul, S.; Euaree, A.; Supatchaipisit, P. 1998: Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer (NSCLC): a preliminary study Journal of the Medical Association of Thailand 81(10): 763-771
Tell, R.; Sederholm, C.; Klintenberg, C.; Franksson, L.; Brandén, E.; Hillerdal, G.; Lönn, U.; Lindén, C.-J.; Ewers, S.-B.ör.; Lamberg, K.; Mrazek, E.; Lödén, B.; Sjögren, A.; Linné, T.; Friesland, S.; Sirzén, F. 2008: Multicentre phase Ii trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer Anticancer Research 28(5b): 2851-2857
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809